#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia recurrent Anti-glomerular basement membrane disease Neurofibroma Sexually transmitted disease Osteomyelitis Anaplastic large cell lymphoma T- and null-cell types Chronic myelomonocytic leukaemia Infective uveitis Congenital cystic kidney disease Hairy cell leukaemia recurrent Fontan procedure Gastrointestinal stromal tumour Non-small cell lung cancer metastatic Univentricular heart Dementia Alzheimer's type More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Basic Information Hereditary neuropathic amyloidosis – Diagnostics Mucopolysaccharidosis II – Basic Information Glycogen storage disease type I – Basic Information Cystic fibrosis Friedreich’s ataxia – Diagnostics Atypical haemolytic uraemic syndrome Small intestine leiomyosarcoma – Diagnostics Gaucher’s disease type III – Diagnostics Primary hyperoxaluria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Remdesivir Arginine Hydrochloride Erenumab Ipratropium Bromide Oxogluric Acid Volixibat Imgn151 Hydrochlorothiazide Esomeprazole Citalopram Hydrobromide Lazertinib Crofelemer Adg126 Topotecan Hydrochloride Pp1493 Elafibranor Efavirenz Anitocabtagene Autoleucel Etifoxine Hydrochloride Teprenone More therapies…

    Learn about Your Condition

    Kearns-Sayre syndrome Follicular thyroid cancer Biliary adenoma Chorioretinitis KBG syndrome Melanoma recurrent Laryngeal cancer stage I K-ras gene mutation Ewing's sarcoma recurrent Meningorrhagia Chorea Rectal adenocarcinoma Premature baby Prostate cancer recurrent Tetanus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac function disturbance postoperative

  • A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • R2R01
    Germany Italy

  • Study on Reducing Acute Kidney Injury After Heart Surgery Using Angiotensin II or Noradrenaline for Patients with Low Blood Pressure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ANGIOTENSIN II
    • Noradrenaline Tartrate
    Germany

  • Study on Fibrinogen Concentrate (FGTW) for Managing Bleeding in Patients Undergoing Complex Cardiac Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    Investigated Drugs:
    • Human Fibrinogen
    Czechia Germany Italy Spain Sweden

  • Study on Preventing Acute Kidney Injury After Heart Surgery Using Empagliflozin in Patients Undergoing Elective Cardiac Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Empagliflozin
    Spain

  • Study on Alkaline Phosphatase to Prevent Inflammation and Kidney Injury in Patients Undergoing Open-Heart Surgery

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    Investigated Drugs:
    • Alkaline Phosphatase, Bovine
    Austria Belgium

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!